Effect of Cucumis Melo L seeds on patients with benign prostatic hypertrophy
- Conditions
- Condition 1: Benign Prostatic Hypertrophy. Condition 2: Lower Urinary Tract Symptoms.Enlarged prostate with lower urinary tract symptomsN40.1
- Registration Number
- IRCT20180712040446N3
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 80
All patients aged 45 to 75 years with BPH who include at least one of the following:
International Score of Prostate Symptoms (IPSS) over 13 at the time of screening
PSA higher than 3 ng / ml.
Prostate volume greater than 30 mm detected by ultrasound
Patients who are able and willing to sign a written consent.
Surgery, infection, lower urinary tract disease (bladder stones, neurogenic bladder, bladder malignancy, urethral stricture, hematuria Gross) Diabetes, Heart disease (heart failure, MI, unstable angina), Hepato-renal disease
Use of drugs affecting the bladder and prostate (anticholinergics, sympathomimetics, antidepressants)
Patients who are unable to use oral medication.
Participate in concurrent drug intervention.
Allergy to medicinal plants.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ??????? ?????? ??? ?????? ????? ???????. Timepoint: Before the intervention and 2 weeks after the intervention. Method of measurement: Questionnaire.;Q max. Timepoint: Before the intervention and 2 weeks after the intervention. Method of measurement: Euroflowmetry.;Prostate volume. Timepoint: Before the intervention and 2 weeks after the intervention. Method of measurement: Sonography.
- Secondary Outcome Measures
Name Time Method Prostate specific antigen (PSA). Timepoint: Before the intervention and 2 weeks after the intervention. Method of measurement: ELISA test.;Drug side effects. Timepoint: During the study and two weeks after the study. Method of measurement: Questionnaire.